Pulmonx (LUNG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual Meeting scheduled for June 4, 2026, at 8:00 AM PT, accessible virtually for all shareholders.
Shareholders are encouraged to review proxy materials online or request copies before May 21, 2026.
Voting matters and shareholder proposals
Election of three directors: Thomas W. Burns, Georgia Garinois-Melenikiotou, and Dana G. Mead, Jr.
Ratification of BDO USA, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Non-binding advisory vote to approve executive compensation (say-on-pay).
Proxy holders may vote on other business arising at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Pulmonx
- Director elections, auditor ratification, and executive pay are key focuses, with enhanced governance and ESG oversight.LUNG
Proxy filing22 Apr 2026 - Zephyr Valve offers a $12B market opportunity with strong clinical and financial performance.LUNG
Investor presentation5 Mar 2026 - 2025 revenue up 8% to $90.5M, with cost cuts and sales force overhaul supporting 2026 growth.LUNG
Q4 20254 Mar 2026 - Q2 revenue hit $20.8M, up 21% YoY, with improved margins and reaffirmed guidance.LUNG
Q2 20242 Feb 2026 - Strong clinical results and workflow innovation position the company for significant growth.LUNG
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Strong U.S. growth, global expansion, and workflow innovation drive future momentum.LUNG
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Q3 2024 revenue up 15.4% to $20.4M, margins steady, net loss narrows, guidance reaffirmed.LUNG
Q3 202417 Jan 2026 - Enhanced strategy and innovation drive growth, with profitability expected on current cash.LUNG
Stifel 2024 Healthcare Conference13 Jan 2026 - Accelerated strategy and workflow innovation drive growth, with 18–22% revenue increase expected.LUNG
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026